Figure 5.

ESCC samples with a higher expression of Msi1 in tumor tissues have a worse clinical outcome. (A) Immunohistochemistry was used to detect the expression patterns of Msi1 in tumor tissues. The correlation of Msi1 expression with clinicopathological characteristics such as (B) stage, (C) lymphatic metastasis and (D) depth of invasion was analyzed at the protein level. (E) Patients with low expression of Msi1 had a better overall survival when cmpared to patients with high expression of Msi1 (*P<0.05). Msi1, musashi1; ESCC, esophageal squamous cell carcinoma. P=0.035.